Two well‐studied splicing factor families, the serine‐rich proteins and the heterogenous nuclear ribonucleoproteins, have been extensively reported in cancers.76, 77 In our study, we constructed an interesting splicing network to illuminate the potential splicing regulatory mechanism. Here, PROS1 is linked to cancer.